|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2009-10-27
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
There are 2 once-daily, fixed-dose-combination, dual-nucleoside analogue tablets: tenofovir 300 mg-emtricitabine 200 mg (TDF-FTC) and abacavir 600 mg-lamivudine 300 mg (ABC-3TC). Which fixed-dose-combination tablet is more effective and safe is uncertain.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adenine,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-HIV Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine,
http://linkedlifedata.com/resource/pubmed/chemical/Dideoxynucleosides,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-B*57:01 antigen,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-B Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/Lamivudine,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphonic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/abacavir, lamivudine drug...,
http://linkedlifedata.com/resource/pubmed/chemical/emtricitabine,
http://linkedlifedata.com/resource/pubmed/chemical/tenofovir
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1537-6591
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
49
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1591-601
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:19842973-Adenine,
pubmed-meshheading:19842973-Adult,
pubmed-meshheading:19842973-Anti-HIV Agents,
pubmed-meshheading:19842973-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:19842973-Deoxycytidine,
pubmed-meshheading:19842973-Dideoxynucleosides,
pubmed-meshheading:19842973-Drug Combinations,
pubmed-meshheading:19842973-Drug Toxicity,
pubmed-meshheading:19842973-Female,
pubmed-meshheading:19842973-HIV Infections,
pubmed-meshheading:19842973-HLA-B Antigens,
pubmed-meshheading:19842973-Humans,
pubmed-meshheading:19842973-Lamivudine,
pubmed-meshheading:19842973-Male,
pubmed-meshheading:19842973-Middle Aged,
pubmed-meshheading:19842973-Phosphonic Acids,
pubmed-meshheading:19842973-Treatment Outcome,
pubmed-meshheading:19842973-Viral Load
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-Lamivudine: a randomized, 96-week trial.
|
|
pubmed:affiliation |
National Centre in HIV Epidemiology and Clinical Research UNSW, 5St Vincent's Centre for Applied Medical Research, Sydney, Australia.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
